223 related articles for article (PubMed ID: 31343348)
21. Genotype-phenotype correlation and course of transthyretin familial amyloid polyneuropathies in France.
Mariani LL; Lozeron P; Théaudin M; Mincheva Z; Signate A; Ducot B; Algalarrondo V; Denier C; Adam C; Nicolas G; Samuel D; Slama MS; Lacroix C; Misrahi M; Adams D;
Ann Neurol; 2015 Dec; 78(6):901-16. PubMed ID: 26369527
[TBL] [Abstract][Full Text] [Related]
22. Clinical manifestations in hereditary amyloidosis with the variant Glu54Gln transthyretin.
Jercan A; Badelita S; Draghici M; Stoica E; Iacob S; Coriu D
Amyloid; 2019; 26(sup1):31-32. PubMed ID: 31343281
[No Abstract] [Full Text] [Related]
23. Cardiac involvement after liver transplantation in patients with Val30Met transthyretin amyloidosis from Majorca focus.
Ripoll-Vera T; Alvarez J; Buades J; Cisneros E; Gomez Y; Melia C; Ferrer A; Losada I; Gonzalez J; Uson M; Figuerola A
Amyloid; 2019; 26(sup1):18-19. PubMed ID: 31343328
[No Abstract] [Full Text] [Related]
24. Family dynamics in transthyretin-related familial amyloid polyneuropathy Val30Met: Does genetic risk affect family functioning?
Lopes A; Rodrigues C; Fonseca I; Sousa A; Branco M; Coelho T; Sequeiros J; Freitas P
Clin Genet; 2018 Nov; 94(5):401-408. PubMed ID: 30019395
[TBL] [Abstract][Full Text] [Related]
25. Liver Transplantation for Hereditary Transthyretin Amyloidosis: After 20 Years Still the Best Therapeutic Alternative?
Ericzon BG; Wilczek HE; Larsson M; Wijayatunga P; Stangou A; Pena JR; Furtado E; Barroso E; Daniel J; Samuel D; Adam R; Karam V; Poterucha J; Lewis D; Ferraz-Neto BH; Cruz MW; Munar-Ques M; Fabregat J; Ikeda S; Ando Y; Heaton N; Otto G; Suhr O
Transplantation; 2015 Sep; 99(9):1847-54. PubMed ID: 26308415
[TBL] [Abstract][Full Text] [Related]
26. Diflunisal compassive use in transthyretin hereditary amyloid polyneuropathy: report of a first Spanish experience.
Azorín SE; Cabib CE; Campistol JM
Amyloid; 2017 Mar; 24(sup1):105-106. PubMed ID: 28434315
[No Abstract] [Full Text] [Related]
27. Cardiac Involvement in a Patient Cohort With Val30Met Mutation Transthyretin Amyloidosis.
Ripoll-Vera T; Buades J; Cisneros E; Gómez Y; Núñez J; Raya M
Rev Esp Cardiol (Engl Ed); 2019 Jan; 72(1):92-94. PubMed ID: 29223374
[No Abstract] [Full Text] [Related]
28. Epidemiological and clinical characteristics of persons with transthyretin hereditary amyloid polyneuropathy: a global synthesis of 532 cases.
Cruz MW; Schmidt H; Botteman MF; Carter JA; Chopra AS; Stewart M; Hopps M; Fallet S; Amass L
Amyloid; 2017 Mar; 24(sup1):109-110. PubMed ID: 28434345
[No Abstract] [Full Text] [Related]
29. Diagnosis of amyloid neuropathy.
Kapoor M; Rossor AM; Jaunmuktane Z; Lunn MPT; Reilly MM
Pract Neurol; 2019 Jun; 19(3):250-258. PubMed ID: 30598431
[TBL] [Abstract][Full Text] [Related]
30. Sporadic Cardiac Amyloidosis by Amyloidogenic Transthyretin V122I Variant.
Nehashi T; Oikawa M; Amami K; Kanno Y; Yokokawa T; Misaka T; Yamada S; Kunii H; Nakazato K; Ishida T; Takeishi Y
Int Heart J; 2019 Nov; 60(6):1441-1443. PubMed ID: 31666456
[TBL] [Abstract][Full Text] [Related]
31. Genotypic and phenotypic presentation of transthyretin-related familial amyloid polyneuropathy (TTR-FAP) in Turkey.
Durmuş-Tekçe H; Matur Z; Mert Atmaca M; Poda M; Çakar A; Hıdır Ulaş Ü; Oflazer-Serdaroğlu P; Deymeer F; Parman YG
Neuromuscul Disord; 2016 Jul; 26(7):441-6. PubMed ID: 27238058
[TBL] [Abstract][Full Text] [Related]
32. Transthyretin related familial amyloid polyneuropathy.
Planté-Bordeneuve V; Said G
Curr Opin Neurol; 2000 Oct; 13(5):569-73. PubMed ID: 11073365
[TBL] [Abstract][Full Text] [Related]
33. Transthyretin-related familial amyloidotic polyneuropathy.
Ando Y; Nakamura M; Araki S
Arch Neurol; 2005 Jul; 62(7):1057-62. PubMed ID: 16009758
[TBL] [Abstract][Full Text] [Related]
34. Characterization of untyped cardiac amyloidosis by mass spectrometry in a patient with Gly6Ser transthyretin polymorphism in fatal cardiogenic shock.
Damy T; Plante-Bordeneuve V; Dogan A
Arch Cardiovasc Dis; 2014 Dec; 107(12):706-8. PubMed ID: 24070596
[No Abstract] [Full Text] [Related]
35. Evolution of amyloid fibrils in hereditary transthyretin amyloidosis: an ultrastructural study.
Koike H; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Katsuno M; Sobue G
Amyloid; 2019; 26(sup1):26. PubMed ID: 31343346
[No Abstract] [Full Text] [Related]
36. Delayed diagnosis of transthyretin amyloidosis with a novel mutation (c.210T>A) in the transthyretin gene.
Dekmezian MS; Tschen JA; Cho-Vega JH
J Am Acad Dermatol; 2013 Feb; 68(2):e49-51. PubMed ID: 23317988
[No Abstract] [Full Text] [Related]
37. Effects of tafamidis on transthyretin stabilization and clinical outcomes in patients with non-Val30Met transthyretin amyloidosis.
Merlini G; Planté-Bordeneuve V; Judge DP; Schmidt H; Obici L; Perlini S; Packman J; Tripp T; Grogan DR
J Cardiovasc Transl Res; 2013 Dec; 6(6):1011-20. PubMed ID: 24101373
[TBL] [Abstract][Full Text] [Related]
38. Comparison of clinical features in transient focal neurological episodes between hereditary transthyretin type and Aβ type cerebral amyloid angiopathy.
Nakajima M; Takeuchi Y; Nagao Y; Masuda T; Yamashita T; Yonehara T; Terasaki T; Ando Y
Amyloid; 2019; 26(sup1):81-82. PubMed ID: 31343286
[No Abstract] [Full Text] [Related]
39. Cardiac findings and events observed in an open-label clinical trial of tafamidis in patients with non-Val30Met and non-Val122Ile hereditary transthyretin amyloidosis.
Damy T; Judge DP; Kristen AV; Berthet K; Li H; Aarts J
J Cardiovasc Transl Res; 2015 Mar; 8(2):117-27. PubMed ID: 25743445
[TBL] [Abstract][Full Text] [Related]
40. First report of a rare mutation in a Polish patient with painful late-onset transthyretin amyloidosis.
Hagenacker T; Brenck J; Kastrup O
J Neurol Sci; 2014 Nov; 346(1-2):331-2. PubMed ID: 25130926
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
